Skip to main content
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
64.26
+0.81 (1.28%)
Nov 22, 2024, 4:00 PM EST - Market closed

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had revenue of $745.74M in the quarter ending September 30, 2024, with 28.28% growth. This brings the company's revenue in the last twelve months to $2.75B, up 19.14% year-over-year. In the year 2023, BioMarin Pharmaceutical had annual revenue of $2.42B with 15.42% growth.

Revenue (ttm)
$2.75B
Revenue Growth
+19.14%
P/S Ratio
4.42
Revenue / Employee
$809,412
Employees
3,401
Market Cap
12.25B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.42B323.19M15.42%
Dec 31, 20222.10B249.76M13.53%
Dec 31, 20211.85B-14.18M-0.76%
Dec 31, 20201.86B156.41M9.18%
Dec 31, 20191.70B212.84M14.27%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG 21.46B
Universal Health Services 15.42B
Solventum 8.22B
Smith & Nephew 5.64B
Dr. Reddy's Laboratories 3.58B
AptarGroup 3.57B
Globus Medical 2.48B
Neurocrine Biosciences 2.24B
Revenue Rankings

BMRN News

More News